Intralesional fibrous septum in chordoma: A clinicopathologic and immunohistochemical study of 122 lesions

American Journal of Clinical Pathology

Volumn 124, Issue 2, 2005, Pages 288-294

  Naka, Takahiko ^a,d   Boltze, Carsten ^a   Kuester, Doerthe ^a   Samii, Amir ^b   Herold, Christian ^b   Ostertag, Helmut ^b   Iwamoto, Yukihide ^c   Oda, Yoshinao ^c   Tsuneyoshi, Masazumi ^c   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b NORDSTADT HOSPITAL   (Germany)

^c KYUSHU UNIVERSITY   (Japan)

^d KYUSHU ROSAI HOSPITAL   (Japan)

Author keywords

Chordoma; Fibrous septum; Invasion; Lobular growth pattern; Prognosis

Indexed keywords

ALPHA ACTIN; ALPHA SMOOTH MUSCLE ACTIN; CATHEPSIN B; CD34 ANTIGEN; COLLAGEN TYPE 4; CYTOKERATIN 8; DESMIN; EPITHELIAL MEMBRANE ANTIGEN; GELATINASE A; GELATINASE B; KI 67 ANTIGEN; PROTEIN S 100; PROTEINASE; UROKINASE; VIMENTIN;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER INFILTRATION; CHILD; CHORDOMA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRALESIONAL FIBROUS SEPTUM; LYMPHOCYTIC INFILTRATION; MALE; MICROSCOPY; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; TUMOR CELL; TUMOR GROWTH;

EID: 23044459881     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/5DLWL8EA7JUDWNVL     Document Type: Article

References (21)

1. Dahlin D, MacCarty C. Chordoma: a study of fifty-nine cases. Cancer. 1952;5:1170-1178.
2. Heffelfinger MJ, Dahlin DC, MacCarty CS, et al. Chordomas and cartilaginous tumors at the skull base. Cancer. 1973;32:410-420.
3. Higinbotham NL, Phillips RF, Farr HW, et al. Chordoma: thirty-five-year study at Memorial Hospital. Cancer. 1967;20:1841-1850.
4. Mirra J. Chordoma. In: Mirra J, ed. Bone Tumors. Philadelphia, PA: Lea & Febiger; 1989:648-669.
5. Rich TA, Schiller A, Suit HE, et al. Clinical and pathologic review of 48 cases of chordoma. Cancer. 1985;56:182-187.
6. Volpe R, Mazabraud A. A clinicopathologic review of 25 cases of chordoma: a pleomorphic and metastasizing neoplasm. Am J Surg Pathol. 1983;7:161-170.
7. Lai ECS, Ng IO, Ng MM, et al. Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathologic features. Hepatology. 1990;11:815-818.
8. Ng IO, Lai EC, Ng MM, et al. Tumor encapsulation in hepatocellular carcinoma: a pathologic study of 189 cases. Cancer. 1992;70:45-49.
9. Okuda K, Musha H, Nakajima Y, et al. Clinicopathologic features of encapsulated hepatocellular carcinoma: a study of 26 cases. Cancer. 1977;40:1240-1245.
10. Maeshima AM, Niki T, Maeshima A, et al. Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma. Cancer. 2002;95:2546-2554.
11. Yokoyama R, Tsuneyoshi M, Enjoji M, et al. Prognostic factors of malignant fibrous histiocytoma of bone: a clinical and histopathologic analysis of 34 cases. Cancer. 1993;72:1902-1908.
12. Shimosato Y, Suzuki A, Hashimoto T, et al. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol. 1980;4:365-373.
13. Naka T, Boltze C, Samii S, et al. Skull base and non-skull base chordomas: clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability. Cancer. 2003;98:1934-1941.
14. Ishizaki M, Ashida K, Higashi T, et al. The formation of capsule and septum in human hepatocellular carcinoma. Virchows Arch. 2001;438:574-580.
15. Folkman J. Tumor angiogenesis. Adv Cancer Res. 1985;43:175-203.
16. Kato T, Kameoka S, Kimura T, et al. The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. Br J Cancer. 2003;88:1900-1908.
17. Morabito A, Magnani E, Gion M, et al. Prognostic and predictive indicators in operable breast cancer. Clin Breast Cancer. 2003;3:381-390.
18. Ushijima C, Tsukamoto S, Yamazaki K, et al. High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression. Lung Cancer. 2001;34:233-241.
19. Morinaga S, Imada T, Shimizu A, et al. Angiogenesis in hepatocellular carcinoma as evaluated by alpha smooth muscle actin immunohistochemistry. Hepatogastroenterology. 2001;48:224-228.
20. Khan AW, Dhillon AP, Hutchins R, et al. Prognostic significance of intratumoral microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival. Eur J Surg Oncol. 2002;28:637-644.
21. Elsobky E, El-Baz M, Gomha M, et al. Prognostic value of angiogenesis in Schistosoma-associated squamous cell carcinoma of the urinary bladder. Urology. 2002;60:69-73.